Psychedelic Therapy for Wellness Studies Retrospectively
NCT05469243 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-08-30
Summary
The overall aim of this study is to assess the efficacy psychedelics for improving measures of wellness using a retrospective, single period, cohort study
Conditions
- Well Aging
Interventions
- DRUG
-
Psychedelic
retrospective survey of previous use
Sponsors & Collaborators
-
Canadian Forces Health Services Centre Ottawa
lead OTHER
Principal Investigators
-
Gaurav Gupta · GG MPC
Eligibility
- Min Age
- 19 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-19
- Primary Completion
- 2025-08-18
- Completion
- 2025-08-27
- FDA Drug
- Yes
Countries
- Canada
Study Locations
More Related Trials
-
Mindfulness and Psychedelics
NCT05780216 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic
NCT04769297 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Drugs on Responses to Brain and Emotional Processes
NCT04053036 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self
NCT03736980 ·Status: COMPLETED ·Phase: NA
-
Behavior Brain Responses
NCT03964350 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Psychedelics and Wellness Study (PAWS)
NCT04040582 ·Status: COMPLETED
-
Ayahuasca, Esketamine and Premenstrual Symptoms
NCT07317232 ·Status: RECRUITING ·Phase: NA
-
Cannabioids as a New Intervention for Amphetamine Dependence
NCT02952196 ·Status: WITHDRAWN ·Phase: PHASE2
-
Ayahuasca, Esketamine and PTSD
NCT07317206 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
NCT05379959 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Personality and Drug Use
NCT05516823 ·Status: UNKNOWN
-
Behavioral Pharmacology of THC and D-limonene
NCT03609853 ·Status: COMPLETED ·Phase: PHASE1
-
Persisting Effects of Psilocybin
NCT02971605 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects
NCT03717272 ·Status: COMPLETED ·Phase: PHASE2
-
MDMA-Assisted Therapy for Pathological Narcissism
NCT06565494 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Marijuana Drug Discrimination and Self-Administration
NCT00943930 ·Status: COMPLETED
-
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
NCT05322954 ·Status: TERMINATED ·Phase: PHASE1
-
PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm
NCT06798636 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes
NCT07214155 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male Subjects
NCT05554926 ·Status: COMPLETED ·Phase: PHASE1
-
Mood and Cognitive Effects of Psilocybin in Healthy Participants
NCT05252598 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship Quality
NCT05670184 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effect of Ketamine on Laboratory-induced Stress in Healthy Subjects
NCT04173962 ·Status: COMPLETED ·Phase: PHASE2
-
Safety for Home Administration of Microdose Psilocybin Use
NCT06450210 ·Status: RECRUITING ·Phase: PHASE1
-
Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation
NCT01037608 ·Status: COMPLETED ·Phase: PHASE1